FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:747-749 February 20, 2003 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Grier, H. E. PubMed Citation

Of the many things that physicians do, participating in cooperative clinical trials is among the strangest. Relatively undervalued in the typical academic promotion-and-tenure process, often inadequately reimbursed by government funding agencies, faced with informed-consent regulations that vastly exceed in degree of disclosure what is required for routine care, and confronting progressively greater degrees of regulation with each passing year, the clinical trialist may be forgiven for occasionally wondering whether society really wants this kind of work to go forward.

In the end, however, it does go forward. Some of the fuel for the engine is a stream of products from . . . [Full Text of this Article]

Source Information

From the Memorial Sloan-Kettering Cancer Center, New York.

This article has been cited by other articles:

• Djulbegovic, B., Kumar, A., Soares, H. P., Hozo, I., Bepler, G., Clarke, M., Bennett, C. L. (2008). Treatment Success in Cancer: New Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute-Sponsored Cooperative Oncology Groups, 1955 to 2006. Arch Intern Med 168: 632-642 [Abstract] [Full Text]  
• Trippel, S. B., Bosse, M. J., Heck, D. A., Wright, J. G. (2007). Symposium. How to Participate in Orthopaedic Randomized Clinical Trials. JBJS 89: 1856-1864 [Full Text]  
• Wright, J. G. (2007). A Practical Guide to Assigning Levels of Evidence. JBJS 89: 1128-1130 [Full Text]  
• Hurwitz, S. R., Tornetta, P. III, Wright, J. G. (2006). An AOA Critical Issue How to Read the Literature to Change Your Practice: An Evidence-Based Medicine Approach. JBJS 88: 1873-1879 [Full Text]  
• Kumar, A., Soares, H., Wells, R., Clarke, M., Hozo, I., Bleyer, A., Reaman, G., Chalmers, I., Djulbegovic, B. (2005). Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ 331: 1295- [Abstract] [Full Text]  
• Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., Shankar, L., Larson, S. M., Sigman, C. C., Schilsky, R. L., Sullivan, D. C. (2005). Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development. Clin. Cancer Res. 11: 2785-2808 [Abstract] [Full Text]